Holen Sie sich die Stockscreener-App
58.33
0.43%
0.25
Handel nachbörslich:
58.73
0.40
+0.69%
Überblick
Nachrichten
Preisverlauf
Optionskette
Warum fällt NVO?
Forum
Prognose
Aktiensplit
Dividendenhistorie
Novo Nordisk Adr Aktie (NVO) Neueste Nachrichten
Novo Nordisk ADR (NVO) Stock: Uncovering a 52-Week Range and Trading Volume - investchronicle.com
Down 61%, Is Novo Nordisk Stock Worth Buying on the Dip? - The Motley Fool
European ADRs Rise As Prudential And BP Lead The Pack - Finimize
NVO Stock Quote Price and Forecast - CNN
European Equities Traded in the US as American Depositary Receipts Rise in Monday Trading - marketscreener.com
Is Novo Nordisk Stock a Buy After its Collapse? - Morningstar
Eli Lilly and Novo Nordisk: Obesity Drug Coverage in Medicare Not a Straight Path - Morningstar
Is Novo Nordisk (NVO) the Best ADR Stock to Buy According to Hedge Funds? - Insider Monkey
Novo Nordisk’s $2B deal for obesity drug a strategic game-changer for US pharmaceutical market - Yahoo Finance
Why Novo Nordisk Stock Dipped on Thursday - Yahoo Finance
Novo Nordis Share Price | NYSE: NVO Stock - Investing.com UK
NOVO_B Stock Price and Chart — OMXCOP:NOVO_B - TradingView
INVESTOR ALERT: Pomerantz Law Firm Announces the Filing of a Class Action Lawsuit Against Novo Nordisk A/SNVO - Finansavisen
Novo Nordisk shares plunge after obesity drug trial - The Irish Independent
Novo Nordisk AS (NVO) Stock Price, Trades & News - GuruFocus.com
Novo Nordisk A/S Sponsored ADR Class B to Host Earnings Call - ACCESS Newswire
META_TITLE_QUOTE - Yahoo Finance
Repare Surprises On Earnings; California Resources Falls Short - Evrim Ağacı
Why weight-loss drugs are the top target of Medicare price negotiations - Equities News
1.64%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):